SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)
RIGL 30.29-1.2%1:02 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: beta007 who wrote (427)2/8/2009 12:34:25 PM
From: mcbio  Read Replies (1) of 566
 
Welcome beta. I assume analysts still like it for the longer-term, as do I. It may be dead money for 6 months or so (actually about 5 as first results are due in July) but it should move significantly upward again after this if the Phase IIb results are good.

So, one shouldn't expect any significant movement in either direction until the results are out in July and August. If you believe the results will be good, as I do, then you should be in the stock before the results are released. That doesn't necessarily mean you should sell the stock now and buy back before the news. I'm going to continue to hold on to what I have now but I'm going to delay adding to my position until shortly before the results are released.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News